| Tag | Content |
|---|
EnhancerAtlas ID | HS064-14198 |
Organism | Homo sapiens |
Tissue/cell | GM18507 |
Coordinate | chr7:99793430-99794510 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr7:99793536-99793551 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10301 | chr7:99792406-99793791 | CD19_Primary | | SE_11379 | chr7:99792157-99794098 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I100195 | chr7 | 99792877 | 99794130 |
|
Enhancer Sequence | TTAATGACCT GATCAAATTA AGTTAAAAAG AATATATGTA GGCCGGGCGT GGTGGCTCAC 60
GCCTGTAATC CCAGCACTTT GGGAGGCCAA GGCAGGCAGA TCACCTGAGG TCAGGAGTTC 120
ACAACCAGCC TGACCAACAT GGAGAAACTC CATCTCTACT GAAAATACAA AATTAGCCGG 180
GTGTGGTGGC GCATCCCTGT AATCCCAGCT GCTCAGGAGG CTGAGGCAGG AGAATCGCTT 240
GAACCCAGGA GGTGGAGGTT GCGGTGAGCT GAGATGACGC CATTGCACTC CAGCCTAGGC 300
AACAAGAGTG AAACTCCATC TCAAAAAAAG AAAAAAAAGA AAAAAAAAAT TGTAGATGTT 360
TCTCACTCTT ACCTAGGTTT CACTTCTGCC TCTCCAGAGC CTTTCAGCTG ATGTAACCTT 420
TTCTTAATGT GGAATTAAAA CACACTCACA CACTTTGGCC AACAGTTGAA TTAACTTTTT 480
TTTTTTTGGC AGGGACGGAG TCTCACTGTG TTGCCCAGGC TGGAGTGCAG TGGTGCGATC 540
TCGGCTCACG GCAAGCCCCA CCCCCCGGGT TTAGGCGATT CTTCTGCCTC AGCCTCCCAA 600
GTAGCTGGGA CTACAGGCGC CCACCACCAT GCTTGGCTAA TTTTTGGCCA CCATGCCCAG 660
CCTGAATGAA CTTTCAAAAT TGGTTTTTAA AAGAGGTATG GAGACCGGGT GCAGTGGCTC 720
ACACCTGTAA CCCCAGCACT TTGGGAGGCC AAGACAGGCA GATCACTTGA GGTCAGGAGT 780
TCGAGACCAG CCTGGCCAAC ATGGCAAAAC CCCGTCTCTA CTAAAAATAC AAAAAGGAAG 840
CTGGGCGTGG TGGTGCACCT GTAATCCCAG CTACTCGGGA GGCTGAGGCA GGAGAATCAC 900
TTGAACCCGA GAGGTAGAGG TTGCAGTGAG CTGAGATTGT GCCGCTGCAC TCCAGCCTGG 960
GCAACAGGTG GAGTGGAGAA TTAGGCTGTA CAAGGCTGGT GTTTAACTAT TTTATGGTTT 1020
GGTAACAGAA AGAAAATATT TACTAACTGG GTATGGCACA TTTTTGTAGT CCTAGCTACT 1080
|
